APO Research
Talk to an analyst

APO RESEARCH · REPORT

Companion Animals Medicines and Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Companion Animals Medicines and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026194 pages

Choose your research edition.

Industry ResearchCompanion Animals Medicines and Vaccines Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Companion Animals Medicines and Vaccines Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Companion Animals Medicines and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Companion Animals Medicines and Vaccines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Companion Animals Medicines and Vaccines Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Companion Animals Medicines and Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Companion Animals Medicines and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Companion Animals Medicines and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Companion Animals Medicines and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Companion Animals Medicines and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Companion Animals Medicines and Vaccines include Boehringer Ingelheim, Ceva, Dechra Veterinary Products, Elanco Animal Health, Meiji, Ouro Fino Saude, Parnell, Vetoquinol and Virbac, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Companion Animals Medicines and Vaccines market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Companion Animals Medicines and Vaccines and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Companion Animals Medicines and Vaccines revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Companion Animals Medicines and Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Companion Animals Medicines and Vaccines Segment by Company

Boehringer Ingelheim

Ceva

Dechra Veterinary Products

Elanco Animal Health

Meiji

Ouro Fino Saude

Parnell

Vetoquinol

Virbac

Zoetis

Bayer Animal Health

Merck Animal Health

Companion Animals Medicines and Vaccines Segment by Type

Medicines

Vaccines

Companion Animals Medicines and Vaccines Segment by Application

Dogs

Cats

Other

Companion Animals Medicines and Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Companion Animals Medicines and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Companion Animals Medicines and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Companion Animals Medicines and Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Companion Animals Medicines and Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Companion Animals Medicines and Vaccines industry.

Chapter 3: Detailed analysis of Companion Animals Medicines and Vaccines companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Companion Animals Medicines and Vaccinesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Companion Animals Medicines and Vaccines Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Medicines Table 3. Key Players of Vaccines Table 4. Global Companion Animals Medicines and Vaccines Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Dogs Table 6. Key Players of Cats Table 7. Key Players of Other Table 8. Global Companion Animals Medicines and Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Companion Animals Medicines and Vaccines Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Companion Animals Medicines and Vaccines Market Share by Region (2021-2026) Table 11. Global Companion Animals Medicines and Vaccines Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Companion Animals Medicines and Vaccines Market Share by Region (2027-2032) Table 13. Companion Animals Medicines and Vaccines Industry Trends Table 14. Companion Animals Medicines and Vaccines Industry Drivers Table 15. Companion Animals Medicines and Vaccines Industry Opportunities and Challenges Table 16. Companion Animals Medicines and Vaccines Industry Restraints Table 17. Global Companion Animals Medicines and Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Companion Animals Medicines and Vaccines Revenue Market Share by Company (2021-2026) Table 19. Global Companion Animals Medicines and Vaccines Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Companion Animals Medicines and Vaccines Key Company Head Office and Area Served Table 21. Global Companion Animals Medicines and Vaccines Company, Product Type & Application Table 22. Global Companion Animals Medicines and Vaccines Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Companion Animals Medicines and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Companion Animals Medicines and Vaccines Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Companion Animals Medicines and Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Companion Animals Medicines and Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Companion Animals Medicines and Vaccines Revenue Market Share by Type (2021-2026) Table 29. Global Companion Animals Medicines and Vaccines Revenue Market Share by Type (2027-2032) Table 30. Global Companion Animals Medicines and Vaccines Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Companion Animals Medicines and Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Companion Animals Medicines and Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Companion Animals Medicines and Vaccines Revenue Market Share by Application (2021-2026) Table 34. Global Companion Animals Medicines and Vaccines Revenue Market Share by Application (2027-2032) Table 35. Boehringer Ingelheim Company Information Table 36. Boehringer Ingelheim Business Overview Table 37. Boehringer Ingelheim Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Boehringer Ingelheim Companion Animals Medicines and Vaccines Product Portfolio Table 39. Boehringer Ingelheim Recent Development Table 40. Ceva Company Information Table 41. Ceva Business Overview Table 42. Ceva Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Ceva Companion Animals Medicines and Vaccines Product Portfolio Table 44. Ceva Recent Development Table 45. Dechra Veterinary Products Company Information Table 46. Dechra Veterinary Products Business Overview Table 47. Dechra Veterinary Products Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Dechra Veterinary Products Companion Animals Medicines and Vaccines Product Portfolio Table 49. Dechra Veterinary Products Recent Development Table 50. Elanco Animal Health Company Information Table 51. Elanco Animal Health Business Overview Table 52. Elanco Animal Health Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Elanco Animal Health Companion Animals Medicines and Vaccines Product Portfolio Table 54. Elanco Animal Health Recent Development Table 55. Meiji Company Information Table 56. Meiji Business Overview Table 57. Meiji Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Meiji Companion Animals Medicines and Vaccines Product Portfolio Table 59. Meiji Recent Development Table 60. Ouro Fino Saude Company Information Table 61. Ouro Fino Saude Business Overview Table 62. Ouro Fino Saude Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Ouro Fino Saude Companion Animals Medicines and Vaccines Product Portfolio Table 64. Ouro Fino Saude Recent Development Table 65. Parnell Company Information Table 66. Parnell Business Overview Table 67. Parnell Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Parnell Companion Animals Medicines and Vaccines Product Portfolio Table 69. Parnell Recent Development Table 70. Vetoquinol Company Information Table 71. Vetoquinol Business Overview Table 72. Vetoquinol Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Vetoquinol Companion Animals Medicines and Vaccines Product Portfolio Table 74. Vetoquinol Recent Development Table 75. Virbac Company Information Table 76. Virbac Business Overview Table 77. Virbac Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Virbac Companion Animals Medicines and Vaccines Product Portfolio Table 79. Virbac Recent Development Table 80. Zoetis Company Information Table 81. Zoetis Business Overview Table 82. Zoetis Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Zoetis Companion Animals Medicines and Vaccines Product Portfolio Table 84. Zoetis Recent Development Table 85. Bayer Animal Health Company Information Table 86. Bayer Animal Health Business Overview Table 87. Bayer Animal Health Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Bayer Animal Health Companion Animals Medicines and Vaccines Product Portfolio Table 89. Bayer Animal Health Recent Development Table 90. Merck Animal Health Company Information Table 91. Merck Animal Health Business Overview Table 92. Merck Animal Health Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Merck Animal Health Companion Animals Medicines and Vaccines Product Portfolio Table 94. Merck Animal Health Recent Development Table 95. North America Companion Animals Medicines and Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 96. North America Companion Animals Medicines and Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 97. North America Companion Animals Medicines and Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 98. North America Companion Animals Medicines and Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 99. North America Companion Animals Medicines and Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Companion Animals Medicines and Vaccines Market Size by Country (2021-2026) Table 101. North America Companion Animals Medicines and Vaccines Market Size by Country (2027-2032) Table 102. Europe Companion Animals Medicines and Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 103. Europe Companion Animals Medicines and Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 104. Europe Companion Animals Medicines and Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 105. Europe Companion Animals Medicines and Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 106. Europe Companion Animals Medicines and Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Companion Animals Medicines and Vaccines Market Size by Country (2021-2026) Table 108. Europe Companion Animals Medicines and Vaccines Market Size by Country (2027-2032) Table 109. China Companion Animals Medicines and Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 110. China Companion Animals Medicines and Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 111. China Companion Animals Medicines and Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 112. China Companion Animals Medicines and Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 113. Asia Companion Animals Medicines and Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 114. Asia Companion Animals Medicines and Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 115. Asia Companion Animals Medicines and Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 116. Asia Companion Animals Medicines and Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 117. Asia Companion Animals Medicines and Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Asia Companion Animals Medicines and Vaccines Market Size by Country (2021-2026) Table 119. Asia Companion Animals Medicines and Vaccines Market Size by Country (2027-2032) Table 120. South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 121. South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 122. South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 123. South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 124. South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Country (2021-2026) Table 126. South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Country (2027-2032) Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Companion Animals Medicines and Vaccines Product Image Figure 2. Global Companion Animals Medicines and Vaccines Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Companion Animals Medicines and Vaccines Market Share by Type: 2025 VS 2032 Figure 4. Medicines Image Figure 5. Vaccines Image Figure 6. Global Companion Animals Medicines and Vaccines Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Companion Animals Medicines and Vaccines Market Share by Application: 2025 VS 2032 Figure 8. Dogs Image Figure 9. Cats Image Figure 10. Other Image Figure 11. Global Companion Animals Medicines and Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 13. Global Companion Animals Medicines and Vaccines Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Companion Animals Medicines and Vaccines Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Companion Animals Medicines and Vaccines Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Companion Animals Medicines and Vaccines Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Companion Animals Medicines and Vaccines Revenue Market Share by Type (2021-2032) Figure 20. Global Companion Animals Medicines and Vaccines Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Companion Animals Medicines and Vaccines Revenue Market Share by Application (2021-2032) Figure 22. North America Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 23. North America Companion Animals Medicines and Vaccines Market Share by Type (2021-2032) Figure 24. North America Companion Animals Medicines and Vaccines Market Share by Application (2021-2032) Figure 25. North America Companion Animals Medicines and Vaccines Market Share by Country (2021-2032) Figure 26. United States Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 27. Canada Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 29. Europe Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 30. Europe Companion Animals Medicines and Vaccines Market Share by Type (2021-2032) Figure 31. Europe Companion Animals Medicines and Vaccines Market Share by Application (2021-2032) Figure 32. Europe Companion Animals Medicines and Vaccines Market Share by Country (2021-2032) Figure 33. Germany Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 34. France Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 36. Italy Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 37. Russia Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 39. China Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 40. China Companion Animals Medicines and Vaccines Market Share by Type (2021-2032) Figure 41. China Companion Animals Medicines and Vaccines Market Share by Application (2021-2032) Figure 42. Asia Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 43. Asia Companion Animals Medicines and Vaccines Market Share by Type (2021-2032) Figure 44. Asia Companion Animals Medicines and Vaccines Market Share by Application (2021-2032) Figure 45. Asia Companion Animals Medicines and Vaccines Market Share by Country (2021-2032) Figure 46. Japan Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 50. India Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 51. Australia Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Share by Country (2021-2032) Figure 56. Brazil Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 61. UAE Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 63. Chile Companion Animals Medicines and Vaccines Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Medicines
  • Vaccines
Applications
  • Dogs
  • Cats
  • Other
Companies covered
  • Boehringer Ingelheim
  • Ceva
  • Dechra Veterinary Products
  • Elanco Animal Health
  • Meiji
  • Ouro Fino Saude
  • Parnell
  • Vetoquinol
  • Virbac
  • Zoetis
  • Bayer Animal Health
  • Merck Animal Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Companion Animals Medicines and Vaccines Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Medicines
  5. 1.2.3 Vaccines
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Companion Animals Medicines and Vaccines Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Dogs
  9. 1.3.3 Cats
  10. 1.3.4 Other
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Companion Animals Medicines and Vaccines Growth Trends by Region
  13. 1.5.1 Global Companion Animals Medicines and Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Companion Animals Medicines and Vaccines Market Size by Region (2021-2026)
  15. 1.5.3 Companion Animals Medicines and Vaccines Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Companion Animals Medicines and Vaccines Market Dynamics
  1. 2.1 Companion Animals Medicines and Vaccines Industry Trends
  2. 2.2 Companion Animals Medicines and Vaccines Industry Drivers
  3. 2.3 Companion Animals Medicines and Vaccines Industry Opportunities and Challenges
  4. 2.4 Companion Animals Medicines and Vaccines Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Companion Animals Medicines and Vaccines Revenue by Company (2021-2026)
  2. 3.2 Global Companion Animals Medicines and Vaccines Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Companion Animals Medicines and Vaccines Key Company Head office and Area Served
  4. 3.4 Global Companion Animals Medicines and Vaccines Company, Product Type & Application
  5. 3.5 Global Companion Animals Medicines and Vaccines Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Companion Animals Medicines and Vaccines Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Companion Animals Medicines and Vaccines Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Companion Animals Medicines and Vaccines Tier 1, Tier 2, and Tier 3
4 Companion Animals Medicines and Vaccines Market by Type
  1. 4.1 Global Companion Animals Medicines and Vaccines Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Companion Animals Medicines and Vaccines Market Size by Type (2021-2032)
  3. 4.3 Global Companion Animals Medicines and Vaccines Market Size Share by Type (2021-2032)
5 Companion Animals Medicines and Vaccines Market by Application
  1. 5.1 Global Companion Animals Medicines and Vaccines Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Companion Animals Medicines and Vaccines Market Size by Application (2021-2032)
  3. 5.3 Global Companion Animals Medicines and Vaccines Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Boehringer Ingelheim
  2. 6.1.1 Boehringer Ingelheim Company Information
  3. 6.1.2 Boehringer Ingelheim Business Overview
  4. 6.1.3 Boehringer Ingelheim Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Boehringer Ingelheim Companion Animals Medicines and Vaccines Product Portfolio
  6. 6.1.5 Boehringer Ingelheim Recent Developments
  7. 6.2 Ceva
  8. 6.2.1 Ceva Company Information
  9. 6.2.2 Ceva Business Overview
  10. 6.2.3 Ceva Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Ceva Companion Animals Medicines and Vaccines Product Portfolio
  12. 6.2.5 Ceva Recent Developments
  13. 6.3 Dechra Veterinary Products
  14. 6.3.1 Dechra Veterinary Products Company Information
  15. 6.3.2 Dechra Veterinary Products Business Overview
  16. 6.3.3 Dechra Veterinary Products Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Dechra Veterinary Products Companion Animals Medicines and Vaccines Product Portfolio
  18. 6.3.5 Dechra Veterinary Products Recent Developments
  19. 6.4 Elanco Animal Health
  20. 6.4.1 Elanco Animal Health Company Information
  21. 6.4.2 Elanco Animal Health Business Overview
  22. 6.4.3 Elanco Animal Health Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Elanco Animal Health Companion Animals Medicines and Vaccines Product Portfolio
  24. 6.4.5 Elanco Animal Health Recent Developments
  25. 6.5 Meiji
  26. 6.5.1 Meiji Company Information
  27. 6.5.2 Meiji Business Overview
  28. 6.5.3 Meiji Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Meiji Companion Animals Medicines and Vaccines Product Portfolio
  30. 6.5.5 Meiji Recent Developments
  31. 6.6 Ouro Fino Saude
  32. 6.6.1 Ouro Fino Saude Company Information
  33. 6.6.2 Ouro Fino Saude Business Overview
  34. 6.6.3 Ouro Fino Saude Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Ouro Fino Saude Companion Animals Medicines and Vaccines Product Portfolio
  36. 6.6.5 Ouro Fino Saude Recent Developments
  37. 6.7 Parnell
  38. 6.7.1 Parnell Company Information
  39. 6.7.2 Parnell Business Overview
  40. 6.7.3 Parnell Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Parnell Companion Animals Medicines and Vaccines Product Portfolio
  42. 6.7.5 Parnell Recent Developments
  43. 6.8 Vetoquinol
  44. 6.8.1 Vetoquinol Company Information
  45. 6.8.2 Vetoquinol Business Overview
  46. 6.8.3 Vetoquinol Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Vetoquinol Companion Animals Medicines and Vaccines Product Portfolio
  48. 6.8.5 Vetoquinol Recent Developments
  49. 6.9 Virbac
  50. 6.9.1 Virbac Company Information
  51. 6.9.2 Virbac Business Overview
  52. 6.9.3 Virbac Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Virbac Companion Animals Medicines and Vaccines Product Portfolio
  54. 6.9.5 Virbac Recent Developments
  55. 6.10 Zoetis
  56. 6.10.1 Zoetis Company Information
  57. 6.10.2 Zoetis Business Overview
  58. 6.10.3 Zoetis Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Zoetis Companion Animals Medicines and Vaccines Product Portfolio
  60. 6.10.5 Zoetis Recent Developments
  61. 6.11 Bayer Animal Health
  62. 6.11.1 Bayer Animal Health Company Information
  63. 6.11.2 Bayer Animal Health Business Overview
  64. 6.11.3 Bayer Animal Health Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Bayer Animal Health Companion Animals Medicines and Vaccines Product Portfolio
  66. 6.11.5 Bayer Animal Health Recent Developments
  67. 6.12 Merck Animal Health
  68. 6.12.1 Merck Animal Health Company Information
  69. 6.12.2 Merck Animal Health Business Overview
  70. 6.12.3 Merck Animal Health Companion Animals Medicines and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Merck Animal Health Companion Animals Medicines and Vaccines Product Portfolio
  72. 6.12.5 Merck Animal Health Recent Developments
7 North America
  1. 7.1 North America Companion Animals Medicines and Vaccines Market Size (2021-2032)
  2. 7.2 North America Companion Animals Medicines and Vaccines Market Size by Type
  3. 7.2.1 North America Companion Animals Medicines and Vaccines Market Size by Type (2021-2026)
  4. 7.2.2 North America Companion Animals Medicines and Vaccines Market Size by Type (2027-2032)
  5. 7.2.3 North America Companion Animals Medicines and Vaccines Market Share by Type (2021-2032)
  6. 7.3 North America Companion Animals Medicines and Vaccines Market Size by Application
  7. 7.3.1 North America Companion Animals Medicines and Vaccines Market Size by Application (2021-2026)
  8. 7.3.2 North America Companion Animals Medicines and Vaccines Market Size by Application (2027-2032)
  9. 7.3.3 North America Companion Animals Medicines and Vaccines Market Share by Application (2021-2032)
  10. 7.4 North America Companion Animals Medicines and Vaccines Market Size by Country
  11. 7.4.1 North America Companion Animals Medicines and Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Companion Animals Medicines and Vaccines Market Size by Country (2021-2026)
  13. 7.4.3 North America Companion Animals Medicines and Vaccines Market Size by Country (2027-2032)
  14. 7.4.4 North America Companion Animals Medicines and Vaccines Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Companion Animals Medicines and Vaccines Market Size (2021-2032)
  2. 8.2 Europe Companion Animals Medicines and Vaccines Market Size by Type
  3. 8.2.1 Europe Companion Animals Medicines and Vaccines Market Size by Type (2021-2026)
  4. 8.2.2 Europe Companion Animals Medicines and Vaccines Market Size by Type (2027-2032)
  5. 8.2.3 Europe Companion Animals Medicines and Vaccines Market Share by Type (2021-2032)
  6. 8.3 Europe Companion Animals Medicines and Vaccines Market Size by Application
  7. 8.3.1 Europe Companion Animals Medicines and Vaccines Market Size by Application (2021-2026)
  8. 8.3.2 Europe Companion Animals Medicines and Vaccines Market Size by Application (2027-2032)
  9. 8.3.3 Europe Companion Animals Medicines and Vaccines Market Share by Application (2021-2032)
  10. 8.4 Europe Companion Animals Medicines and Vaccines Market Size by Country
  11. 8.4.1 Europe Companion Animals Medicines and Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Companion Animals Medicines and Vaccines Market Size by Country (2021-2026)
  13. 8.4.3 Europe Companion Animals Medicines and Vaccines Market Size by Country (2027-2032)
  14. 8.4.4 Europe Companion Animals Medicines and Vaccines Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Companion Animals Medicines and Vaccines Market Size (2021-2032)
  2. 9.2 China Companion Animals Medicines and Vaccines Market Size by Type
  3. 9.2.1 China Companion Animals Medicines and Vaccines Market Size by Type (2021-2026)
  4. 9.2.2 China Companion Animals Medicines and Vaccines Market Size by Type (2027-2032)
  5. 9.2.3 China Companion Animals Medicines and Vaccines Market Share by Type (2021-2032)
  6. 9.3 China Companion Animals Medicines and Vaccines Market Size by Application
  7. 9.3.1 China Companion Animals Medicines and Vaccines Market Size by Application (2021-2026)
  8. 9.3.2 China Companion Animals Medicines and Vaccines Market Size by Application (2027-2032)
  9. 9.3.3 China Companion Animals Medicines and Vaccines Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Companion Animals Medicines and Vaccines Market Size (2021-2032)
  2. 10.2 Asia Companion Animals Medicines and Vaccines Market Size by Type
  3. 10.2.1 Asia Companion Animals Medicines and Vaccines Market Size by Type (2021-2026)
  4. 10.2.2 Asia Companion Animals Medicines and Vaccines Market Size by Type (2027-2032)
  5. 10.2.3 Asia Companion Animals Medicines and Vaccines Market Share by Type (2021-2032)
  6. 10.3 Asia Companion Animals Medicines and Vaccines Market Size by Application
  7. 10.3.1 Asia Companion Animals Medicines and Vaccines Market Size by Application (2021-2026)
  8. 10.3.2 Asia Companion Animals Medicines and Vaccines Market Size by Application (2027-2032)
  9. 10.3.3 Asia Companion Animals Medicines and Vaccines Market Share by Application (2021-2032)
  10. 10.4 Asia Companion Animals Medicines and Vaccines Market Size by Country
  11. 10.4.1 Asia Companion Animals Medicines and Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Companion Animals Medicines and Vaccines Market Size by Country (2021-2026)
  13. 10.4.3 Asia Companion Animals Medicines and Vaccines Market Size by Country (2027-2032)
  14. 10.4.4 Asia Companion Animals Medicines and Vaccines Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Companion Animals Medicines and Vaccines Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst